A detailed history of Toronto Dominion Bank transactions in Organon & Co. stock. As of the latest transaction made, Toronto Dominion Bank holds 290 shares of OGN stock, worth $4,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
290
Previous 323 10.22%
Holding current value
$4,358
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $615 - $759
-33 Reduced 10.22%
290 $5,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $885,340 - $1.4 Million
-80,853 Reduced 99.6%
323 $4,000
Q3 2023

Feb 14, 2024

BUY
$16.59 - $23.77 $131,708 - $188,710
7,939 Added 10.84%
81,176 $1.41 Million
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $131,708 - $188,710
7,939 Added 10.84%
81,176 $1.41 Million
Q2 2023

Feb 14, 2024

BUY
$19.27 - $24.63 $1.41 Million - $1.8 Million
72,914 Added 22573.99%
73,237 $1.52 Million
Q2 2023

Aug 10, 2023

BUY
$19.27 - $24.63 $293,443 - $375,065
15,228 Added 26.25%
73,237 $1.52 Million
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $84,737 - $126,908
3,956 Added 7.32%
58,009 $1.36 Million
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $31,864 - $39,109
-1,367 Reduced 2.47%
54,053 $1.51 Million
Q3 2022

Nov 09, 2022

SELL
$23.4 - $34.25 $438,469 - $641,776
-18,738 Reduced 25.27%
55,420 $1.3 Million
Q2 2022

Aug 11, 2022

SELL
$31.66 - $38.9 $713,109 - $876,183
-22,524 Reduced 23.3%
74,158 $2.5 Million
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $100,271 - $129,612
-3,293 Reduced 3.29%
96,682 $3.38 Million
Q4 2021

Feb 04, 2022

SELL
$28.67 - $37.13 $116,228 - $150,525
-4,054 Reduced 3.9%
99,975 $3.04 Million
Q3 2021

Nov 08, 2021

BUY
$28.63 - $35.64 $611,221 - $760,878
21,349 Added 25.82%
104,029 $3.41 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $2.35 Million - $3.14 Million
82,680 New
82,680 $2.5 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.